Dental Care Clinics in East Hanover, NJ Accepting Medicare
7 Dental Care Clinics found. Showing 1 - 7
 Dental Care East Hanover Llc Dentist Medicare: Not Enrolled in Medicare Practice Location: 320 Nj-10, Dental Care East Hanover, East Hanover, NJ 07936 Phone: 973-975-0309 |
Tdk Dental Llc Dba Family Friendly Dental Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 470 Ridgedale Ave, East Hanover, NJ 07936 Phone: 973-884-1046 |
Ejs Dental Llc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 470 Ridgedale Ave, East Hanover, NJ 07936 Phone: 973-992-3990 |
East Hanover Family Dental Dentist Medicare: Not Enrolled in Medicare Practice Location: 49 Ridgedale Ave, East Hanover, NJ 07936 Phone: 973-884-1144 |
John J. Graeber Dmd (pa) Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 470 Ridgedale Ave, East Hanover, NJ 07936 Phone: 973-884-1046 Fax: 973-884-0498 |
David F Romano Dmd Pa Dentist Medicare: Not Enrolled in Medicare Practice Location: 49 Ridgedale Ave, Ste 202, East Hanover, NJ 07936 Phone: 201-884-1144 Fax: 973-884-3144 |
Slobodian Dental Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 49 Ridgedale Ave Ste 201, East Hanover, NJ 07936 Phone: 973-822-1200 Fax: 973-822-8454 |
News Archive
Belatacept costimulation blocker can prevent rejection of new organs by the immune system
Initial results of a study conducted at 100 centers worldwide indicate that belatacept, a first-in-class costimulation blocker can prevent the immune system rejecting new organs. The results also suggest that it may provide similar patient and graft survival to cyclosporine but with fewer side effects and superior kidney function after 12 months. The study, published today in the American Journal of Transplantation, provides the first findings to come from BENEFIT (Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial).
New laboratory approach could aid brain recovery
In humans, active periods of the debilitating disease Multiple Sclerosis (MS) can last for mere minutes or extend to weeks at a time. They're caused by lesions in the brain that develop, partly heal, and then recur. Research into a cure has been difficult, because to date scientists have not been able to replicate these brain recurring symptoms in laboratory mice. That's frustrating because these lab animals, known as animal "models," are the primary tool for research into the mechanisms and potential treatments for MS.
Research sheds light on episodic memory
Memories of events comprise many components-including sights, sounds, smells, and tastes. Somehow the many features of an episodic memory are woven together into a coherent whole, and researchers have had little understanding of how this binding takes place as the memories are processed by the brain's memory center, the hippocampus.
Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee
Eli Lilly and Company have announced that the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration positively endorsed Alimta® (pemetrexed), an antifolate, for accelerated approval in the second-line treatment of non-small cell lung cancer.
› Verified 2 days ago